Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.59
-0.16-5.82%
At close: Jun 5, 5:00 PM EST
$2.57
-0.02-0.77%
After Hours: Jun 5, 4:01 PM EST
Cellectar Biosciences Inc Analyst Ratings
CLRBNASDAQ
Cellectar Biosciences Analyst Ratings and Price Targets | NASDAQ:CLRB | Benzinga
Cellectar Biosciences Inc has a consensus price target of $16 based on the ratings of 4 analysts. The high is $28 issued by Roth MKM on March 28, 2024. The low is $10 issued by Ladenburg Thalmann on May 15, 2026. The 3 most-recent analyst ratings were released by Ladenburg Thalmann, Maxim Group, and Oppenheimer on May 15, 2026, March 10, 2026, and November 19, 2024, respectively. With an average price target of $10.67 between Ladenburg Thalmann, Maxim Group, and Oppenheimer, there's an implied 315.05% upside for Cellectar Biosciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Ladenburg Thalmann
Maxim Group
Roth MKM
1calculated from analyst ratings
Analyst Ratings for Cellectar Biosciences
Loading calendar...
FAQ
What is the target price for Cellectar Biosciences (CLRB) stock?
The latest price target for Cellectar Biosciences (NASDAQ:CLRB) was reported by Ladenburg Thalmann on May 15, 2026. The analyst firm set a price target for $10.00 expecting CLRB to rise to within 12 months (a possible 289.11% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cellectar Biosciences (CLRB)?
The latest analyst rating for Cellectar Biosciences (NASDAQ:CLRB) was provided by Ladenburg Thalmann, and Cellectar Biosciences their buy rating.
When was the last upgrade for Cellectar Biosciences (CLRB)?
The last upgrade for Cellectar Biosciences Inc happened on March 10, 2026 when Maxim Group raised their price target to $10. Maxim Group previously had a hold for Cellectar Biosciences Inc.
When was the last downgrade for Cellectar Biosciences (CLRB)?
The last downgrade for Cellectar Biosciences Inc happened on May 14, 2025 when Maxim Group changed their price target from N/A to N/A for Cellectar Biosciences Inc.
When is the next analyst rating going to be posted or updated for Cellectar Biosciences (CLRB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cellectar Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cellectar Biosciences was filed on May 15, 2026 so you should expect the next rating to be made available sometime around May 15, 2027.
Is the Analyst Rating Cellectar Biosciences (CLRB) correct?
While ratings are subjective and will change, the latest Cellectar Biosciences (CLRB) rating was a with a price target of $0.00 to $10.00. The current price Cellectar Biosciences (CLRB) is trading at is $2.57, which is within the analyst’s predicted range.
